Model of the catalytic mechanism of human aldose reductase based on quantum chemical calculations

被引:28
作者
Cachau, R
Howard, E
Barth, P
Mitschler, A
Chevrier, B
Lamour, V
Joachimiak, A
Sanishvili, R
Van Zandt, M
Sibley, E
Moras, D
Podjarny, A
机构
[1] IGBMC, UPR Biol Struct, F-67404 Illkirch Graffenstaden, France
[2] NCI, SAIC, Adv Biomed Comp Ctr, Frederick, MD 21701 USA
[3] Univ Louis Pasteur Strasbourg 1, Inst Chim, Lab Chim Organ Biol, F-67008 Strasbourg, France
[4] Argonne Natl Lab, Biosci Div, Argonne, IL USA
[5] Inst Diabet Discovery Inc, Branford, CT USA
来源
JOURNAL DE PHYSIQUE IV | 2000年 / 10卷 / P10期
关键词
D O I
10.1051/jp4:20001001
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
Aldose Reductase is an enzyme involved in diabetic complications, thoroughly studied for the purpose of inhibitor development. The structure of an enzyme-inhibitor complex solved at sub-atomic resolution has been used to develop a model for the catalytic mechanism. This model has been refined using a combination of Molecular Dynamics and Quantum calculations. It shows that the proton donation, the subject of previous controversies, is the combined effect of three residues: Lys 77, Tyr 48 and His 110. Lys 77 polarises the Tyr 48 OH group, which donates the proton to His 110, which becomes doubly protonated. His 110 then moves and donates the proton to the substrate. The key information from the sub-atomic resolution structure is the orientation of the ring and the single protonation of the His 110 in the enzyme-inhibitor complex. This model is in full agreement with all available experimental data.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 22 条
[1]   TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN THE REDUCTION REACTION OF HUMAN ALDOSE REDUCTASE - ENZYME-KINETICS AND CRYSTAL-STRUCTURE OF THE Y48H MUTANT ENZYME [J].
BOHREN, KM ;
GRIMSHAW, CE ;
LAI, CJ ;
HARRISON, DH ;
RINGE, D ;
PETSKO, GA ;
GABBAY, KH .
BIOCHEMISTRY, 1994, 33 (08) :2021-2032
[2]  
DVORNIK D, 1988, POLYOL PATHWAY ITS R, P61
[3]  
DVORNIK D, 1994, DESIGN ENZYME INHIBI, V2, P710
[4]  
El-Kabbani O, 1999, MOL VIS, V5, pU1
[5]  
Frisch M.J., 2016, Gaussian 16 Revision C. 01. 2016, V16, P01
[6]  
GONEN A, 1995, CLIN SCI DIABETES, P313
[7]   INFLUENZA-A VIRUS M(2) ION-CHANNEL PROTEIN - A STRUCTURE-FUNCTION ANALYSIS [J].
HOLSINGER, LJ ;
NICHANI, D ;
PINTO, LH ;
LAMB, RA .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1551-1563
[8]  
HOWARD E, 1999, ACTA CRYST A S, V55
[9]   SHORT-CHAIN DEHYDROGENASES REDUCTASES (SDR) [J].
JORNVALL, H ;
PERSSON, B ;
KROOK, M ;
ATRIAN, S ;
GONZALEZDUARTE, R ;
JEFFERY, J ;
GHOSH, D .
BIOCHEMISTRY, 1995, 34 (18) :6003-6013
[10]   Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase [J].
Lee, YS ;
Chen, Z ;
Kador, PF .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (10) :1811-1819